See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← SALME page
XStocksXray
Market X-Ray report · 23 October 2026

Salmon Evolution Holding AS (SALME)

Oslo Stock Exchange · Norway · prices in NOK · close of 23 Oct 2026

Key indicators

Last closeNOK 3.100
52-week range3.025 – 5.470
Return, 1 month / 3 months−7.6% / −23.4%
Return, 1 year / 3 years−41.1% / −47.5%
TrendBelow its 200-day average
RSI (14)41
Volatility (1 year)30.2%
Worst drawdown (1 year)-44.1%
Average daily value traded4.23M NOK
Dividend yield–

Market X-Ray price-based

30/ 100 · High confidence · ahead of 21% of stocks on this exchange
Trend14
Momentum12
Stability (higher is calmer)47
Liquidity59
Income–

Five-year price chart navy: price · brown: 200-day average

2.534.837.139.4311.732021-102023-012024-042025-072026-10

About the company

Salmon Evolution is a Norwegian aquaculture company that raises Atlantic salmon on land rather than in open sea pens. It uses a hybrid flow-through system at its facility on the island of Indre Harøy in western Norway, where it hatches, grows and harvests fish. The company supplies Atlantic salmon to seafood buyers and markets that want a land-based source of farmed fish, and it is based in Norway.

The shares are listed on the Oslo Stock Exchange in Norway under the code SALME, and the price on this page is in Norwegian kroner (NOK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Salmon Evolution Holding AS (SALME) trades on the Oslo Stock Exchange in Norway. It last closed at NOK 3.100 on 23 October 2026.

Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 233 of 294 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 41.1% and over the last three months it fell 23.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Salmon Evolution Holding AS (SALME)

The five lenses in numbers each metric is ranked against the other stocks on Oslo Stock Exchange

Lens and metricValueScoreReading
Trend14 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-26.7%
From 52-week high-42.7%
Momentum12 · WeakLagging most stocks on this exchange.
3-month return-23.4%
6-month return-36.0%
12-month return, skipping the last month-36.2%
Stability (higher is calmer)47 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)30.2%
Worst drawdown, 1 year (smaller is calmer)-44.1%
Liquidity59 · FairModerate trading activity.
Average daily value traded4.23M NOK
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−3.3%
1 month−7.6%
3 months−23.4%
6 months−36.0%
1 year−41.1%
3 years−47.5%
5 years−60.3%

Signals

50-day / 200-day average3.423 / 4.228
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.117

Technical summary

DailyStrongly bearish0 bullish · 4 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 0 neutral · 11 bearish
MonthlyStrongly bearish1 bullish · 0 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Oslo Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026